CAS 925069-34-7

Formula: C16H16ClN3O2S2

InChI: InChI=1S/C16H16ClN3O2S2/c1-3-11-8(2)24-15(12(11)13(18)21)20-16(23)19-14(22)9-4-6-10(17)7-5-9/h4-7H,3H2,1-2H3,(H2,18,21)(H2,19,20,22,23)

InChI key: MIERMBQDBLFAFW-UHFFFAOYSA-N

SMILES: CCC1=C(SC(=C1C(=O)N)NC(=S)NC(=O)C2=CC=C(C=C2)Cl)C

PI-273

CAS: 925069-34-7

PI-273, a Substrate-Competitive, Specific Small-Molecule Inhibitor of PI4KIIα, Inhibits the Growth of Breast Cancer Cells

Formula: C₁₆H₁₆ClN₃O₂S₂

Purity: 99.63%

Color and Shape: Solid

Molecular weight: 381.9

Ref: TM-T12454

PI-273

CAS: 925069-34-7

Formula: C₁₆H₁₆ClN₃O₂S₂

Purity: %

Color and Shape: Solid

Molecular weight: 381.9001

Ref: IN-DA01V4ZU

PI-273

CAS: 925069-34-7

PI-273

Formula: C₁₆H₁₆ClN₃O₂S₂

Purity: ≥90%

Molecular weight: 381.9

Ref: 54-BUP12684

2-({[(4-Chlorophenyl)carbonyl]carbamothioyl}amino)-4-ethyl-5-methylthiophene-3-carboxamide

CAS: 925069-34-7

2-({[(4-Chlorophenyl)carbonyl]carbamothioyl}amino)-4-ethyl-5-methylthiophene-3-carboxamide (MOCA) is a hydrogen bond inhibitor. It has been studied in animal models for the treatment of cancer and as an antiherpetic agent. MOCA binds to the 5-HT7 receptor, which is involved in regulating sleep, appetite, and mood. MOCA can be used as a potential antiinflammatory agent for the treatment of hepatitis and other diseases. MOCA also inhibits protein synthesis by binding to ribosomes and inhibiting rRNA synthesis.

Formula: C₂₂H₁₉N₅O₂S

Purity: Min. 95%

Molecular weight: 417.5 g/mol

Ref: 3D-AMB06934